Arno Therapeutics Announces Three Poster Presentations at ASCO Annual Meeting.
PARSIPPANY, N.J. -- Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced that three poster presentations will be presented from the recently completed Phase I trial for its produ...